2025 Q3 Quarterly Activities Report & Appendix 4C
| Stock | Imexhs Ltd (IME.ASX) |
|---|---|
| Release Time | 31 Oct 2025, 8:33 a.m. |
| Price Sensitive | Yes |
IMEXHS Reports Q3 FY25 Results, Reconfirms Guidance
- Q3 FY25 revenue up 9% vs pcp, up 3% on constant currency basis
- YTD FY25 revenue up 6% excluding one-off, up 5% on constant currency basis
- Q3 FY25 Underlying EBITDA of $0.6m, up from break-even in pcp
IMEXHS Limited (ASX: IME) reported its quarterly cash flow and activities summary for the period ended 30 September 2025. Q3 FY25 revenue was $7.2m, up 9% vs pcp and up 3% on a constant currency basis. YTD FY25 revenue was $20.8m, up 6% excluding a one-off of $0.7m in pcp and up 5% on a constant currency basis. Q3 FY25 Underlying EBITDA was $0.6m, up from break-even in pcp. YTD FY25 Underlying EBITDA was $0.9m, up from $0.2m in pcp. Annualised Recurring Revenue (ARR) was $36.4m as of 30 September 2025, up 24% vs pcp and 12% up on a constant currency basis. The company reconfirmed its FY25 guidance of revenue in the range of $27.5m to $28.2m, up 4.0 to 6.6% on the prior year, and Underlying EBITDA in the range of $1.3m to $1.6m, up from $0.5m in the prior year. The company saw strong traction in its software business, including regaining a flagship private hospital contract in Ecuador and renewing and upgrading a contract in Peru. The partner network remained a core growth engine, with 26 active partners across 14 countries. In the Radiology Services segment, RIMAB signed a one-year agreement to deliver high-complexity radiology services to Oncolife in Colombia, expected to contribute $1.4m in New Annual Recurring Revenue. The company continued to make progress on its product roadmap, with enhancements to the Aquila+ RIS, Patient Portal, Universal Viewer, and DICOM Gateway.
Revenue in the range $27.5m to $28.2m - up 4.0 to 6.6% on the prior year; and Underlying EBITDA in the range $1.3m to $1.6m - up vs $0.5m in the prior year.
The company's priority over the next 12 months is to strengthen and grow the software business across the region - expanding Aquila+ and the Enterprise cloud footprint - through a balanced mix of direct sales and high-performing partners. The company expects to improve margins in the software business over the next six to nine months.